Recombinant SARS-CoV-2 Spike RBD-SD1(V367F)(His Tag)
Recombinant SARS-CoV-2 Spike RBD-SD1(V367F)(His Tag) supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["PKSR030477Immobilized Human ACE-2-Fc(PKSR030492) at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1-His(PKSR030477). The ED50 of PKSR030477 is 1.7ug/ml. PKSV030386Immobilized Human ACE-2-Fc(PKSR030492) at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1(V367F, C-6His)(PKSV030386). The ED50 of PKSV030386 is 0.8ug/ml. , PKSR030477Immobilized Anti-2019-nCoV S1 mAb (5D9)at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1-His(PKSR030477). The ED50 of PKSR030477 is 1. 28 ug/ml. PKSV030386Immobilized Anti-2019-nCoV S1 mAb (5D9)at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1(V367F, C-6His)(PKSV030386). The ED50 of PKSV030386 is 2. 55 ug/ml. ,30-40 kDa"]Product Description
SARS-CoV-2 Spike RBD-SD1(V367F) is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: SARS-CoV-2; expression system: HEK293 Cells; physical form: Supplied as a 0.2 μm filtered solution of PBS, pH7.4.; tag: SARS-CoV-2 ,SARS-CoV-2 Spike RBD-SD1(V367F) ,Recombinant Proteins; predicted molecular weight: 31.4 kDa.
Quality and formulation: purity: > 95 % as determined by reducing SDS-PAGE.; concentration: Subject to label value..
Functional evidence: activity: PKSR030477Immobilized Human ACE-2-Fc(PKSR030492) at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1-His(PKSR030477). The ED<sub>50</sub> of PKSR030477 is 1.7ug/ml. PKSV030386Immobilized Human ACE-2-Fc(PKSR030492) at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1(V367F, C-6His)(PKSV030386). The ED<sub>50</sub> of PKSV030386 is 0.8ug/ml. , PKSR030477Immobilized Anti-2019-nCoV S1 mAb (5D9)at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1-His(PKSR030477). The ED<sub>50</sub> of PKSR030477 is 1. 28 ug/ml. PKSV030386Immobilized Anti-2019-nCoV S1 mAb (5D9)at 5μg/ml (100 μl/well) can bind 2019-nCoV S Protein RBD-SD1(V367F, C-6His)(PKSV030386). The ED<sub>50</sub> of PKSV030386 is 2. 55 ug/ml.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 31.4 kDa.
Database references: UniProt: QHD43416.1 | NCBI Gene: 43740568 | Gene symbol: SARS-CoV-2 Spike RBD-SD1(V367F).
Research Use Only.
Key Facts
| Target | SARS-CoV-2 Spike RBD-SD1(V367F) |
| Also known as | 2019-nCoV S protein RBD, S protein RBD, SARS-CoV-2 Spike RBD |
| Concentration | Subject to label value. |
| Species reactivity | SARS-CoV-2 |
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Form / buffer | Supplied as a 0.2 μm filtered solution of PBS, pH7.4. |
| Shelf life | 6 months |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| SARS-CoV-2 |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.